• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

Medtronic Hits Our Price Target: Time to Take Profits?

A follow-up to our story in June.
By BRUCE KAMICH
Sep 16, 2019 | 11:27 AM EDT
Stocks quotes in this article: MDT

Back in early June we reviewed the charts and indicators of Medtronic, Inc. ( MDT) and we wrote that "In this Point and Figure chart of MDT, below, we can see a $108 price target but trades at $98.39 and $99.37 are needed to confirm the uptrend." Those trades happened and prices reached our target last month and pushed a little higher recently.
 
Is this the time to take profits? Let's check the charts again.
 
In the updated daily candlestick chart of MDT, below, we can see an upper shadow above $110 showing that the new price area was rejected. The On-Balance-Volume (OBV) line shows a small double top and small bearish divergence as prices made a new high but the OBV line did not.
 
In the lower panel is the 12-day price momentum study, which shows another bearish divergence from late August into September as momentum weakens even though prices make new highs.

In the weekly candle chart, below, we can see that prices made a possible high-wave candle, which can become a reversal pattern. MDT is above the rising 40-week moving average line.

The weekly OBV line is pointed up but well below the high made last September. The 12-week momentum study shows that momentum is slowing.

In this updated Point and Figure chart of MDT, below, we can see that prices reached and passed the adjusted price target of $105.02.

 
Bottom-line strategy: MDT could be making a small reversal pattern. With some bearish divergences developing and reaching a longer-term price target this becomes a good reason to nail down some profits on MDT.
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Stocks | Technical Analysis | Health Care Equipment & Services | Healthcare

More from Stocks

The Market Has Been Forgiving for Way Too Long

Timothy Collins
Apr 19, 2021 2:09 PM EDT

At some point, the momentum and frothy traders will return, but the current action should be a solid lesson.

Bad Markets Don't Scare You Out, They Wear You Out

James "Rev Shark" DePorre
Apr 19, 2021 1:40 PM EDT

If the S&P 500 was acting like the majority of small-caps we would be calling this a bear market.

T-Mobile's Charts Are About to Ring Dollar Signs

Bruce Kamich
Apr 19, 2021 1:30 PM EDT

Here's our latest technical analysis and trading strategy on TMUS.

Jim Cramer: For GameStop, It's Now All About the Plan

Jim Cramer
Apr 19, 2021 12:37 PM EDT

With George Sherman out as CEO, everything, including every mistake, is now on Ryan Cohen.

Market Volatility Is the Ideal Gauge of Sentiment

Bob Lang
Apr 19, 2021 12:00 PM EDT

Keep an eye on the VIX -- and remember the old saying about when it's low.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 08:05 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    How recency bias and the Pareto Principle impact y...
  • 02:42 PM EDT PAUL PRICE

    Wednesday on Real Money Pro

    Make this stock a 'part' of your portfolio.
  • 04:44 PM EDT PAUL PRICE

    Pretty Incredible + Hard to Believe

  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login